Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 1/2 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 8NIH 3INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Genitourinary 1

Conditions

Neoplasms 1905Breast Neoplasms 1425Carcinoma, Non-Small-Cell Lung 1178Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 623Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Lymphoma 374Recurrence 373Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Interventions

Cinacalcet 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Hyperparathyroidism × Clear all
NCT03123406 2024-04-29

ACTIVE

Kyowa Kirin Co., Ltd.

Phase 4 Completed
750 enrolled
GenitourinaryHead & Neck

Hyperparathyroidism, Hyperparathyroidism, Secondary, Neoplasm Metastasis, Chronic Kidney Disease-Mineral and Bone Disorder

NCT01935856 2017-03-03

Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Kyowa Kirin Co., Ltd.

Phase 1/2 Completed
20 enrolled
Head & Neck

Hyperparathyroidism, Neoplasm Metastasis

NCT00037518 2013-05-08

A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

Amgen

Phase 4 Completed
46 enrolled
Head & Neck

Hyperparathyroidism, Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡